跳至主要内容
临床试验/NCT03858426
NCT03858426Unknown不适用

Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis

Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
Complete histological remission

研究概览

简要总结

  1. Registry of demographic, clinical, endoscopic and histological data at baseline.
  2. Registry of patients treated with PPI:
  • Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
  • Clinical, endoscopic and histological response at 6 and 12 months weeks of maintenance treatment
  1. Registry of patients treated with two foods elimination diet:
  • Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
  • Identification of food trigger: milk, gluten or milk and gluten
  • Clinical, endoscopic and histological response at one year elimination of food trigger
  • Registry of adverse events
  1. Registry of patients treated with swallowed steroids (budesonide or fluticasone):
  • Clinical, endoscopic and histological response at 8-12 weeks of induction treatment
  • Clinical, endoscopic and histological response at 6 months of maintenance steroid treatment
  • Registry of adverse events

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Month 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children from 1 month to 18 years with a new diagnosis of eosinophilic esophagitis (EoE) according to the recent European guidelines (symptoms of esophageal dysfunction + eosinophilic infiltrate of the esophagus > 15 eos / CGA)
  • And that they need to start treatment with any of the following options: PPI, diet excluding cow's milk and gluten, or swallowed corticosteroids .

排除标准

  • Presence of pathological eosinophilia at the gastric or duodenal level (eosinophilic gastroenteritis)
  • Simultaneous treatment with more than one treatment modality (PPI, empirical elimination diet, swallowed corticosteroids).

结局指标

主要结局

Complete histological remission

时间窗: 12 weeks

Complete histological remission response defined as ≤5 eosinophils/hpf in all biopsies performed

次要结局

  • Partial histological remission(12 weeks)
  • Clinical remission(12 weeks)

研究者

发起方
Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carolina Gutierrez Junquera

Principal Investigator

Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica

研究点 (1)

Loading locations...

相似试验